ATTOAPOLLO Trademark Application Published for Opposition
Summary
The USPTO has published the ATTOAPOLLO trademark application for opposition. This trademark application covers a wide range of research preparations, reagents, and diagnostic tools for medical, veterinary, and scientific research purposes. The publication marks a step in the trademark registration process, allowing for potential objections before final approval.
What changed
The United States Patent and Trademark Office (USPTO) has published the trademark application for "ATTOAPOLLO" (TM79444740) for opposition. The application covers extensive categories of research preparations, including antibodies, nucleic acid probes, clinical research reagents, chemical reagents for medical and veterinary research, diagnostic assay reagents, aptamers, and affinity reagents. It also includes non-medical chemical reagents and fluorescent dyes for industrial and scientific use.
This publication is a procedural step in the trademark registration process, indicating that the application has passed initial examination and is now open for a period of opposition from third parties. Companies involved in pharmaceutical research, diagnostics, and scientific supply may wish to monitor this application to assess potential impacts on their own branding or market space. No immediate compliance actions are required for regulated entities, as this pertains to trademark registration rather than direct regulatory obligations.
Source document (simplified)
← USPTO Trademark Applications
ATTOAPOLLO
Published for Opposition TM79444740 Kind: published Mar 26, 2026
Abstract
Research preparations, namely antibodies or nucleic acid probes, for the investigation of disease models; preparations for medical and veterinary research; reagents containing primary antibodies for research use; chemical reagents and medical preparations for research purposes; clinical research reagents; chemical reagents for medical or veterinary research purposes, namely reagents for immuno-histochemistry detection and in situ-hybridisation detection; in situ-hybridisation probes for medical research purposes; epitope retrieval solutions for medical research purposes; enzymes and enzyme preparations for medical research purposes; histological dye and stain solutions for medical research purposes; dewaxing and wash buffers used with the aforementioned preparations; fluorescent dyes and fluorescent labels for diagnostic use; assay reagents for diagnostic use; aptamers for diagnostic use; affinity reagents for diagnostic use; supramolecular host-guest systems for diagnostic use; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for diagnostic use; kits comprising a combination of any of the aforesaid research reagents, preparations for medical and veterinary research, clinical research reagents, in situ-hybridisation probes, epitope retrieval solutions, enzymes and enzyme preparations, histological dyes and stain solutions, dewaxing and wash buffers, fluorescent dyes and fluorescent labels, assay reagents, aptamers, affinity reagents, supramolecular host-guest systems, reagents containing primary antibodies, affimers, or other affinity reagents, nucleic acid probes, non-optically detectable labels, blocking agents and inactivation agents, all for diagnostic and medical research purposes.; Chemicals for use in industry and science; chemical reagents for non-medical purposes; reagents for research purposes; research reagents and preparations, except for medical or veterinary use; research preparations used in science; chemical reagents and diagnostic preparations for use in research laboratories and for use in industry; fluorescent dyes and fluorescent labels for applications in industry and science; assay reagents for use in research, quality control, diagnostic use; aptamers for use in research, quality control; affinity reagents for use in research or quality control; supramolecular host-guest systems for use in research or quality control; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for research use; kits comprising a combination of any of the aforesaid chemical reagents, research reagents and preparations, assay reagents, affinity reagents, supramolecular host-guest systems, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents and inactivation agents, all for industrial, scientific and research use.
Filing Date
2025-11-19
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.